Dodji Modjinou, M.D.
Rheumatology Physician in Henderson, Nevada.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 6,377 in Rheumatology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
What the federal data shows
Dodji Modjinou, M.D. reported a CMS MIPS final score of 80.2/100 - below the 83.5 national average - and filed 1,475 Medicare Part D claims in 2024.
- 80.2/100
- MIPS score · -3 vs avg
- 1K
- Part D claims, 2024
- Likely
- board-certified (heuristic)
- ≥30th
- pct among measured MIPS (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Dodji Modjinou, M.D.
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1710120068), first enumerated 04/16/2009.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 1,475 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 80.2/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Industry payment transparency
$436.3 in reported industry payments (6 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1710120068 · Rheumatology Physician
NPI-10 · ENUM-MID · TAX-MID · MIPS-BELOW · RX-MID · BOOK-THIN · PHOTO-FINISH
- NPI-10 1710120068
- ENUM-MID 2009
- TAX-MID 6K Rheumatology Physician
- MIPS-BELOW 80.2/100
- RX-MID 1,475
- BOOK-THIN 36 in Nevada
- PHOTO-FINISH Robert Bunning, M.D. · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Modjinou · this …
Modjinou · this provider
80.2 MIPS pts
- Soumya Rao, M.D.…
Soumya Rao, M.D.
80.2 MIPS pts
- Robert Bunning, …
Robert Bunning, M.D.
80.2 MIPS pts
- Lanaya Smith, M.…
Lanaya Smith, M.D
80.2 MIPS pts
- William Schnitz,…
William Schnitz, MD
80.2 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Dodji Modjinou, M.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
80 ≥ 30th percentile 30% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Dodji Modjinou, M.D. sits
This provider among rheumatology physician peers
Across the 1,970 rheumatology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Dodji Modjinou, M.D. writes more Part D claims than 41% of them and scores higher on MIPS quality than 31% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one rheumatology physician peer from a representative sample of 60; the gold marker is Dodji Modjinou, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Dodji Modjinou, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Dodji Modjinou, M.D.?
Near national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Nevada
How Rheumatology Physician compares to other specialties among Nevada providers
Rheumatology Physician ranks #134 among Nevada's specialties (0% of in-state providers)
Each bar is a specialty's share of the Nevada provider total, by primary NUCC taxonomy. The highlighted bar is Rheumatology Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Dodji Modjinou, M.D.'s 2023 MIPS final score plotted against the Rheumatology Physician national average
- MIPS Final Score
- 80.2/100
- vs 83.5 national avg · 2023 performance year
Quality benchmarks
- National MIPS avg 2023 measured reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Rheumatology Physician US NPIs
80.2/100 MIPS final score - 3.3 pts below the 83.5 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Rheumatology Physician. Quality dim: 77.2. Cost dim: 59.3.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1710120068 |
|---|---|
| Specialty | Rheumatology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 04/16/2009 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Dodji Modjinou, M.D.'s current license status, disciplinary history, and board certifications with the Nevada State Board of Medical Examiners in Nevada before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1710120068 is the unique 10-digit identifier CMS uses to link Modjinou across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Dodji Modjinou, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$436
Largest payer
GENZYME CORPORATION
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
Prescribing Breakdown
- 30-Day Fills
- 3,053.967
- Total Day Supply
- 88,201
- Generic Drug Cost
- $40K
Patient Demographics
- Average Patient Age
- 69.2 years
- Avg HCC Risk Score
- 1.69
- Gender Split
- 78% female / 22% male
- Age Distribution
- <65: 54, 65-74: 121, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Dodji Modjinou, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Methotrexate
Methotrexate
243 claims
- Prednisone
Prednisone
227 claims
- Hydroxychloroquine…
Hydroxychloroquine Sulfate
147 claims
- Methylprednisolone 81
Methylprednisolone
81 claims
- Gabapentin 62
Gabapentin
62 claims
- Sulfasalazine 55
Sulfasalazine
55 claims
- Amlodipine Besylate 47
Amlodipine Besylate
47 claims
- Folic Acid 46
Folic Acid
46 claims
| Drug | Claims |
|---|---|
| Methotrexate Methotrexate Sodium | 243 |
| Prednisone | 227 |
| Hydroxychloroquine Sulfate | 147 |
| Methylprednisolone | 81 |
| Gabapentin | 62 |
| Sulfasalazine | 55 |
| Amlodipine Besylate | 47 |
| Folic Acid | 46 |
| Leflunomide | 40 |
| Pilocarpine Hcl | 33 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Rheumatology Physician Overview
How Dodji Modjinou, M.D. fits within the Rheumatology Physician landscape nationally.
Dodji Modjinou, M.D.'s 1,475 claims are below the specialty average of 2,058.
Nationwide Rheumatology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Modjinou, both outside Nevada so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (80.2 here).
Same NPPES enumeration year (2009)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Rheumatology Physician Providers in Nevada
Other clinicians with the same primary specialty enrolled in Nevada, drawn from the same CMS NPPES roster as Modjinou.
One of 36 Rheumatology Physician providers enrolled in Nevada, 5 are shown here.
Compare Rheumatology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Dodji Modjinou, M.D.'s specialty? ▼
How much does Dodji Modjinou, M.D. prescribe under Medicare Part D? ▼
What is Dodji Modjinou, M.D.'s Medicare quality score? ▼
Where is Dodji Modjinou, M.D. located? ▼
What is Dodji Modjinou, M.D.'s NPI number? ▼
How many Rheumatology Physician providers are there in the US? ▼
What drugs does Dodji Modjinou, M.D. prescribe most often? ▼
Does Dodji Modjinou, M.D. accept Medicare? ▼
How can I verify Dodji Modjinou, M.D.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.